Pharma & drug development · Reference
What is Good Manufacturing Practice (GMP)?
Good Manufacturing Practice (GMP) is the quality system that ensures medicines are consistently produced and controlled to the standards required for their intended use. It governs everything from facilities and equipment to records and testing.
What GMP controls
GMP is built on the principle that quality must be designed and built into a product, not merely tested at the end. It sets requirements across the whole manufacturing operation: validated processes, qualified equipment, clean and controlled facilities, trained staff, and complete batch records that document exactly how each lot was made and tested. cGMP — “current” Good Manufacturing Practice — signals that manufacturers must keep pace with up-to-date methods and technologies rather than relying on practices that were once acceptable. The goal is consistency: a patient should receive a medicine of the same quality regardless of which batch they happen to be given.
Standards and the ICH Q-series
Pharmaceutical-quality expectations are harmonised internationally through the ICH Q-series of guidelines, which cover topics such as quality risk management (Q9), the pharmaceutical quality system (Q10) and stability testing (Q1). Regulators including the FDA, the EMA and the MHRA each publish and enforce GMP requirements that align with these frameworks. Because manufacturing supply chains are global, a medicine sold in one country may be made in another, so harmonised GMP standards allow mutual recognition of inspections and a common baseline of quality.
Inspection and enforcement
Compliance with GMP is verified through regulatory inspection. Inspectors visit manufacturing sites to examine records, observe processes and confirm that the quality system works in practice, not just on paper. Sites that meet the standard may receive certification permitting them to supply regulated markets.
Where serious deficiencies are found, regulators can issue warning letters, withhold approval, or trigger product withdrawals such as recalls. GMP therefore sits at the centre of pharmaceutical quality assurance, linking the manufacturing floor to the regulatory oversight that allows a product to reach patients.
Key facts
At a glance
- Definition: Quality system for consistent medicine manufacture
- cGMP: “Current” GMP — keep methods up to date
- Covers: Facilities, equipment, processes, records, testing
- Harmonised: ICH Q-series quality guidelines
- Enforced by: FDA, EMA, MHRA via inspection
- Principle: Quality built in, not tested in at the end
Common questions
FAQ
What does GMP stand for?+
GMP stands for Good Manufacturing Practice, the system of regulations that ensures medicines are consistently made to a defined quality. It is a manufacturing-quality and regulatory standard, not a clinical one.
What is the difference between GMP and cGMP?+
They describe the same standard; the “c” in cGMP stands for “current”, emphasising that manufacturers must use up-to-date technologies and systems. US regulations refer to cGMP, while many other regions simply say GMP.
Who enforces GMP?+
National regulators enforce GMP — the FDA in the United States, the EMA and national agencies in the EU, and the MHRA in the UK — primarily through inspections of manufacturing sites and review of quality records.
The step most authors miss
Doing CRediT right? Don’t stop at the statement.
A CRediT statement credits you inside one paper. The recognition CRediT was built for happens when those roles are tied to you, persistently. Sign in with your ORCID — free — and claim your CRediT contributions on casrai.org, the home of the standard. They become a verified, portable part of your identity, not a line that disappears into one PDF.
Free: claim your contributions, then export a journal-ready CRediT statement, schema.org structured data, JATS XML, CSV or BibTeX — and preview your public profile. A membership publishes that profile publicly and verifies the journals you serve.
